Safety and Efficacy Study of Several Replagal Dosing Regimens on Cardiac Function in Adults With Fabry Disease
NCT00864851
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
44
Enrollment
INDUSTRY
Sponsor class
Conditions
Fabry Disease
Interventions
BIOLOGICAL:
Replagal
Sponsor
Shire